CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.096
-0.024 (-1.12%)
Sep 11, 2026, 9:45 AM EDT - Market open
CalciMedica Employees
CalciMedica had 15 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year.
Employees
15
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,327,500
Market Cap
14.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 15 | 0 | - |
| Mar 31, 2026 | 16 | 1 | 6.67% |
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Sep 30, 2025 | 15 | 2 | 15.38% |
| Jun 30, 2025 | 15 | 2 | 15.38% |
| Mar 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 14 | 1 | 7.69% |
| Sep 30, 2024 | 13 | -1 | -7.14% |
| Jun 30, 2024 | 13 | -1 | -7.14% |
| Mar 31, 2024 | 13 | 1 | 8.33% |
| Sep 30, 2023 | 14 | 2 | 16.67% |
| Jun 30, 2023 | 14 | 2 | 16.67% |
| Mar 31, 2023 | 12 | 0 | - |
| Sep 30, 2022 | 12 | 0 | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| PDS Biotechnology | 21 |
| BioCardia | 21 |
| Moleculin Biotech | 17 |
| NeuroSense Therapeutics | 17 |
| BioVie | 13 |
CALC News
- 3 days ago - CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 13 days ago - Calcimedica Inc trading halted, news pending - TheFly
- 15 days ago - CalciMedica to effect 1-for-5 reverse stock split - TheFly
- 15 days ago - CalciMedica Announces One-for-Five Reverse Stock Split - GlobeNewsWire
- 22 days ago - CalciMedica initiated with a Buy at Guggenheim - TheFly
- 4 weeks ago - CalciMedica Quarterly report: Q2 2026 - Filings
- 6 weeks ago - CalciMedica announces FDA alignment on Phase 2b Auxora trial design - TheFly
- 6 weeks ago - CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright - TheFly